Clinical Trials Directory

Trials / Completed

CompletedNCT02636413

Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance

Evaluation of the Impact of LacTEST on Diagnostic Thinking and on Patient Management, and of the Reproducibility (Test-Retest), for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1 (actual)
Sponsor
VenterPharma · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate both the impact of LacTEST on diagnostic thinking and on patient management, and its reproducibility (Test-Retest), for the diagnosis of hypolactasia in adults and elderly patients presenting with clinical symptoms of lactose intolerance.

Conditions

Interventions

TypeNameDescription
DRUGgaxiloseAfter gaxilose administration, urine collection, cuantification (firstly from 0 to 4 hours, and total urine from 0 to 5 hours), and xilose cuantification afterwards.
DIETARY_SUPPLEMENTlactoseAfter lactose administration, expired hydrogen measurement at pre-specified intervals.

Timeline

Start date
2015-10-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2015-12-21
Last updated
2016-12-28

Locations

6 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02636413. Inclusion in this directory is not an endorsement.